Vivos Therapeutics, Inc. Proceeds from Issuance of Debt
Vivos Therapeutics, Inc. (VVOS) reported Proceeds from Issuance of Debt of $1.26 million for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2022-03-31
- Vivos Therapeutics, Inc. proceeds from issuance of debt for the quarter ending 2020-12-31 was -$67.00.
- Vivos Therapeutics, Inc. proceeds from issuance of debt for the quarter ending 2020-09-30 was $0.00.
- Vivos Therapeutics, Inc. proceeds from issuance of debt for fiscal 2020 was $1.26M, a 66.35% decline from fiscal 2019.
- Vivos Therapeutics, Inc. proceeds from issuance of debt for fiscal 2019 was $3.76M.
| Period end | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 9 month | Proceeds from Issuance of Debt 12 month | Proceeds from Issuance of Debt 12 month as first filed |
|---|---|---|---|---|---|
| 2020-12-31 | -$67.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-31 | -$67.00 derived: sum of 2 quarters · filed 2022-03-31 | $1.26M 10-K · filed 2022-03-31 | $1.27M 10-K · filed 2021-03-25 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $1.27M 10-Q · filed 2021-11-15 | |||
| 2020-06-30 | $1.27M 10-Q · filed 2021-08-12 | ||||
| 2019-12-31 | $3.76M 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |